Bausch Health Announces US$50 Million Share Repurchase Program
Stocks in this Quantisnow insightHealth Care
Historical context for BHC
Across the 27 sessions after earlier BHC headlines, the stock closed higher 14 times and lower 12 times, with a median move of 2.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BHC | SPY |
|---|---|---|---|
| Oct 29, 2026 | BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE | +28.8% | -0.4% |
| Oct 19, 2026 | Bausch Health Canada Announces Expanded Public Reimbursement for (Pr)OKEDI® (Risperidone for Extended-Release Injectable Suspension) Across Canada for the Treatment of Schizophrenia | +0.3% | +0.4% |
| Oct 12, 2026 | Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway | -1.8% | -0.1% |
| Oct 6, 2026 | Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026 | +2.2% | +0.5% |
| Sep 8, 2026 | Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Marketsand 1 other headline that session | -2.0% | -0.5% |
| Sep 1, 2026 | Bausch Health Announces Availability of Solta Medical's Fraxel FTX® in Australia | +1.6% | -0.7% |
Quantisnow market dataNYSE
BHC
Bausch Health Companies Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for BHC
Full BHC profile on Quantisnow Follow BHC and get a push notification the moment its next story breaks.